The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci
- 4 June 1999
- Vol. 17 (20-21), 2677-2689
- https://doi.org/10.1016/s0264-410x(99)00049-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Immunogenicity of Two Efficacious Outer Membrane Protein‐Based Serogroup B Meningococcal Vaccines among Young Adults in IcelandThe Journal of Infectious Diseases, 1998
- Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, BrazilThe Lancet, 1992
- Effect of outer membrane vesicle vaccine against group B meningococcal disease in NorwayThe Lancet, 1991
- Meningococcal Disease: Still with UsClinical Infectious Diseases, 1983
- Serum Antibodies to Capsular Polysaccharide Vaccine of Group A Neisseria meningitidis Followed for Three Years in Infants and ChildrenThe Journal of Infectious Diseases, 1980
- EFFECT OF GROUP-A MENINGOCOCCAL VACCINE IN ARMY RECRUITS IN FINLANDThe Lancet, 1975
- Immunologic Response of Man to Group B Meningococcal Polysaccharide VaccinesThe Journal of Infectious Diseases, 1972
- THE RELATIONSHIP BETWEEN GROUP A AND GROUP C MENINGOCOCCAL POLYSACCHARIDES AND SERUM OPSONINS IN MANThe Journal of Experimental Medicine, 1970
- Prevention of Meningococcal Disease by Group C Polysaccharide VaccineNew England Journal of Medicine, 1970
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969